pay-to-delay

Conspiracy theories tagged "pay-to-delay."

2 articles

Pharmaceutical Patent Evergreening

Pharmaceutical companies routinely file trivial modifications to existing drug patents to extend monopoly pricing by decades, blocking cheaper generics — a confirmed, legal but widely criticized practice.

1980 · United States · Pharmaceutical companies, FDA, Patent office

Confirmed Economics & Society

Pay-to-Delay / Reverse Payment Settlement Conspiracy

Brand-name drug companies pay generic manufacturers to delay market entry, confirmed by the FTC as anticompetitive. The Supreme Court ruled in FTC v. Actavis (2013) that these deals can violate antitrust law.

1990 · United States · FTC, Pharmaceutical companies, Generic manufacturers